HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qinhuai Lai Selected Research

duocarmycin A

1/2018Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qinhuai Lai Research Topics

Disease

13Neoplasms (Cancer)
01/2021 - 09/2014
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2021 - 12/2020
2Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 09/2014
2Body Weight (Weight, Body)
12/2018 - 01/2018
1Stomach Neoplasms (Stomach Cancer)
01/2021
1Gastritis
01/2021
1Breast Neoplasms (Breast Cancer)
08/2020
1Fibrosis (Cirrhosis)
01/2019
1Carcinoma (Carcinomatosis)
01/2019
1Colonic Neoplasms (Colon Cancer)
01/2019
1Inflammation (Inflammations)
01/2019
1Lung Neoplasms (Lung Cancer)
01/2018

Drug/Important Bio-Agent (IBA)

6Immunoconjugates (Immunoconjugate)IBA
08/2020 - 01/2017
5Pharmaceutical PreparationsIBA
08/2020 - 09/2014
3Trastuzumab (Herceptin)FDA Link
08/2020 - 09/2014
2Glycoproteins (Glycoprotein)IBA
12/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2019 - 01/2016
2Monoclonal AntibodiesIBA
01/2018 - 01/2017
2human ERBB2 proteinIBA
01/2017 - 09/2014
1GSK 1363089IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1CytokinesIBA
12/2020
1Interleukin-2 (IL2)IBA
12/2020
1Chimeric Antigen ReceptorsIBA
12/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2020
1AntigensIBA
12/2020
1cryptophycin 55IBA
08/2020
1ProdrugsIBA
08/2020
1serum P-component (CIt)IBA
08/2020
1Hydroxyl RadicalIBA
08/2020
1Therapeutic UsesIBA
08/2020
1oil red OIBA
01/2019
1nilotinibFDA Link
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1Eosine Yellowish-(YS) (Eosin)IBA
01/2019
1firsocostatIBA
01/2019
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Tubulin ModulatorsIBA
08/2018
1duocarmycin AIBA
01/2018
1PlatinumIBA
01/2018
1AntibodiesIBA
01/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1TubulinIBA
01/2016
1NPI 2358IBA
01/2016
1NocodazoleIBA
01/2016
1ARQ 197IBA
01/2016
1ColchicineFDA LinkGeneric
01/2016
1Ado-Trastuzumab EmtansineIBA
09/2014

Therapy/Procedure

8Therapeutics
01/2021 - 09/2014
4Immunotherapy
01/2021 - 01/2018
2Drug Therapy (Chemotherapy)
01/2021 - 01/2016
2Aftercare (After-Treatment)
12/2018 - 01/2018
1Intraperitoneal Injections
09/2014